IP Library Granted Patent US 10,208,091
Granted Patent B2
US 10,208,091 · App. 15/526,849 · Granted Feb 19, 2019

Modified kappa light chain-binding polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,091
App. No.
15/526,849
Granted
Feb 19, 2019
Kind
B2
Abstract

A kappa light chain-binding polypeptide comprising or consisting essentially of one or more binding domains of Peptostreptococcus Protein L, each of said domains being selected from the group consisting of domain 2, domain 3 and domain 4.

Claims (13)

1. A polypeptide comprising the amino acid sequence selected from the group consisting of sequences defined by SEQ ID NOS: 15-18.

2. The polypeptide of claim 1 , further comprising at the C-terminus or N-terminus one or more coupling elements, selected from the group consisting of a cysteine residue, a plurality of lysine residues and a plurality of histidine residues.

3. The polypeptide of claim 1 , further comprising an N-terminal moiety.

4. The polypeptide of claim 1 , further comprising a C-terminal moiety.

5. A nucleic acid or a vector encoding a polypeptide according to claim 1 .

6. An expression system, which comprises a nucleic acid or vector according to claim 5 .

7. A separation matrix, wherein a plurality of polypeptides or multimers of claim 1 have been coupled to a solid support.

8. The separation matrix according to claim 7 , wherein the polypeptides or multimers have been coupled to the solid support by multipoint attachment.

9. The separation matrix according to claim 7 , wherein the solid support is a polysaccharide.

10. The polypeptide of claim 1 , comprising the amino acid sequence defined by SEQ ID NO:15.

11. The polypeptide of claim 1 , comprising the amino acid sequence defined by SEQ ID NO:16.

12. The polypeptide of claim 1 , comprising the amino acid sequence defined by SEQ ID NO:17.

13. The polypeptide of claim 1 , comprising the amino acid sequence defined by SEQ ID NO:18.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 042909/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: RODRIGO, GUSTAV; BJORKMAN, TOMAS; ANDER, MATS
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 042379/0052 →